Ergoteles’s Integral Ad Science IAS Stock Holding History

Ergoteles’s Portfolio IAS Stock Details IAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-65,989	Closed	-$1.19M	–	415
2023 Q2	$1.19M	Buy	+65,989	New	+$1.11M	0.06%	418

Other funds holding IAS

VEPM

Vista Equity Partners Management San Francisco, California $42.7M AUM 16.65% 1-Year Est. Return

AVA

Atlas Venture Advisors Boston, Massachusetts $122M AUM 26.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sunriver Management Greenwich, Connecticut $591M AUM 2.74% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

ECM

Engle Capital Management Greenwich, Connecticut $293M AUM 68.31% 1-Year Est. Return

Ergoteles's IAS Position: Q3 2023 in Review

Ergoteles sold out of Integral Ad Science (IAS) in Q3 2023, closing a stake of 65,989 shares — an estimated $1.19M sold.

Ergoteles first reported a position in IAS in Q2 2023 and held it in 1 quarter. The position peaked at $1.19M in Q2 2023. 163 funds tracked by Wall St. Rank hold IAS as of Q3 2023.

Ergoteles reported no remaining Integral Ad Science position as of Q3 2023 after selling out during the quarter.
Ergoteles sold 65,989 Integral Ad Science shares in Q3 2023, an estimated $1.19M.
Ergoteles first reported a position in Integral Ad Science in Q2 2023 and held it in 1 quarter.
Ergoteles's Integral Ad Science position peaked at $1.19M in Q2 2023.
163 funds tracked by Wall St. Rank held Integral Ad Science as of Q3 2023.

Based on Ergoteles's 13F filing for Q3 2023, filed 14 Nov 2023.